137 related articles for article (PubMed ID: 24882183)
1. The costs of social anxiety disorder: the role of symptom severity and comorbidities.
Stuhldreher N; Leibing E; Leichsenring F; Beutel ME; Herpertz S; Hoyer J; Konnopka A; Salzer S; Strauss B; Wiltink J; König HH
J Affect Disord; 2014 Aug; 165():87-94. PubMed ID: 24882183
[TBL] [Abstract][Full Text] [Related]
2. Excess costs of social anxiety disorder in Germany.
Dams J; König HH; Bleibler F; Hoyer J; Wiltink J; Beutel ME; Salzer S; Herpertz S; Willutzki U; Strauß B; Leibing E; Leichsenring F; Konnopka A
J Affect Disord; 2017 Apr; 213():23-29. PubMed ID: 28188993
[TBL] [Abstract][Full Text] [Related]
3. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
Zámbori J; Szádóczky E; Rózsa S; Füredi J
J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
[TBL] [Abstract][Full Text] [Related]
5. The economic burden of anxiety disorders in the 1990s.
Greenberg PE; Sisitsky T; Kessler RC; Finkelstein SN; Berndt ER; Davidson JR; Ballenger JC; Fyer AJ
J Clin Psychiatry; 1999 Jul; 60(7):427-35. PubMed ID: 10453795
[TBL] [Abstract][Full Text] [Related]
6. Reduction in Costs after Treating Comorbid Panic Disorder with Agoraphobia and Generalized Anxiety Disorder.
Ikic V; Belanger C; Bouchard S; Gosselin P; Langlois F; Labrecque J; Dugas MJ; Marchand A
J Ment Health Policy Econ; 2017 Mar; 20(1):11-20. PubMed ID: 28418834
[TBL] [Abstract][Full Text] [Related]
7. Economic costs of anxiety disorders.
DuPont RL; Rice DP; Miller LS; Shiraki SS; Rowland CR; Harwood HJ
Anxiety; 1996; 2(4):167-72. PubMed ID: 9160618
[TBL] [Abstract][Full Text] [Related]
8. Medical and productivity costs of anxiety disorders: case control study.
Marciniak M; Lage MJ; Landbloom RP; Dunayevich E; Bowman L
Depress Anxiety; 2004; 19(2):112-20. PubMed ID: 15022146
[TBL] [Abstract][Full Text] [Related]
9. Cost of anxiety disorders: impact of comorbidity.
Souêtre E; Lozet H; Cimarosti I; Martin P; Chignon JM; Adès J; Tignol J; Darcourt G
J Psychosom Res; 1994; 38 Suppl 1():151-60. PubMed ID: 7799247
[TBL] [Abstract][Full Text] [Related]
10. The effect of comorbid major depressive disorder or bipolar disorder on cognitive behavioral therapy for social anxiety disorder.
Fracalanza K; McCabe RE; Taylor VH; Antony MM
J Affect Disord; 2014 Jun; 162():61-6. PubMed ID: 24767007
[TBL] [Abstract][Full Text] [Related]
11. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort.
Wacker ME; Kitzing K; Jörres RA; Leidl R; Schulz H; Karrasch S; Karch A; Koch A; Vogelmeier CF; Holle R
Int J Chron Obstruct Pulmon Dis; 2017; 12():3437-3448. PubMed ID: 29270005
[TBL] [Abstract][Full Text] [Related]
12. The longitudinal prediction of costs due to health care uptake and productivity losses in a cohort of employees with and without depression or anxiety.
Geraedts AS; Fokkema M; Kleiboer AM; Smit F; Wiezer NW; Majo MC; van Mechelen W; Cuijpers P; Penninx BW
J Occup Environ Med; 2014 Aug; 56(8):794-801. PubMed ID: 25099404
[TBL] [Abstract][Full Text] [Related]
13. Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis.
Konnopka A; König H
Pharmacoeconomics; 2020 Jan; 38(1):25-37. PubMed ID: 31646432
[TBL] [Abstract][Full Text] [Related]
14. Costs of depression in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Fernández A; Alberti C; Sabes-Figuera R; Molina C; Knapp M
J Affect Disord; 2011 Jul; 132(1-2):130-8. PubMed ID: 21402411
[TBL] [Abstract][Full Text] [Related]
15. Human and economic burden of generalized anxiety disorder.
Hoffman DL; Dukes EM; Wittchen HU
Depress Anxiety; 2008; 25(1):72-90. PubMed ID: 17146763
[TBL] [Abstract][Full Text] [Related]
16. Predominantly Inattentive Type of ADHD is Associated With Social Anxiety Disorder.
Koyuncu A; Ertekin E; Yüksel Ç; Aslantaş Ertekin B; Çelebi F; Binbay Z; Tükel R
J Atten Disord; 2015 Oct; 19(10):856-64. PubMed ID: 24813648
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
18. Social anxiety disorder: what are we losing with the current diagnostic criteria?
Filho AS; Hetem LA; Ferrari MC; Trzesniak C; Martín-Santos R; Borduqui T; de Lima Osório F; Loureiro SR; Busatto Filho G; Zuardi AW; Crippa JA
Acta Psychiatr Scand; 2010 Mar; 121(3):216-26. PubMed ID: 19694635
[TBL] [Abstract][Full Text] [Related]
19. Social anxiety disorder in callers to the Anxiety Disorders Association of America.
Zhang W; Ross J; Davidson JR
Depress Anxiety; 2004; 20(3):101-6. PubMed ID: 15484222
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
Bereza BG; Machado M; Einarson TR
Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
